MENLO PARK, Calif. — PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced new workflows developed with global agriculture company, Corteva Agriscience that enable high throughput plant and microbial genome sequencing. This collaboration, which originated at the Advances in Genome Biology and Technology (AGBT) Agricultural meeting last year, delivers end-to-end workflows that streamline DNA extraction […]
SAN CARLOS, Calif. — Factorial Biotechnologies, an emerging single-cell sequencing company with a novel intracellular library preparation technology, has announced a collaboration with Watchmaker Genomics, a life sciences company that specializes in developing high-stringency applications for reading, writing, and editing of DNA and RNA. This collaboration will focus on further optimizing a disruptive technology that enables […]
New England Biolabs® (NEB®) – a global leader in the discovery and production of enzymes for molecular biology applications – has announced it is establishing its first overseas product development and manufacturing site at Milton Park, one of the UK’s leading life science clusters. NEB Lyophilization Sciences™ is a wholly owned subsidiary of NEB and […]
As demand for clinical next-generation sequencing grows, Illumina Connected Insights enables user to streamline data interpretation and report generation to inform precision care SAN DIEGO — Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced the release of Connected Insights, a new cloud-based software enabling tertiary analysis for clinical next-generation sequencing […]
SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, issued the following statement in response to a letter from Carl Icahn dated March 24, 2023: Directors and Officers (D&O) insurance and corporate indemnification are standard for Delaware companies, and support directors in making decisions in the best interests of […]
Life sciences veteran will continue to drive commercial excellence, build on company’s legacy to propel future strategic growth CORALVILLE, Iowa — Global genomics solutions provider Integrated DNA Technologies (IDT) announced it has appointed Linda De Jesus as vice president and general manager, global head of commercial, adding a new leader to the company’s executive team. De Jesus brings […]
New York – Gencove, pioneer of low-pass whole genome sequencing and analysis software, is pleased to announce the appointment of Dr. Alex Dickinson to its Board of Directors. Alex brings deep commercial and technical experience in the genomics and molecular diagnostics industry. He joins Joseph Pickrell and Tomaz Berisa, co-founders of Gencove, Sara Eshelman of […]
Nanopore sequencing offers a transformational new approach for robust and accurate genetic characterisation of biological materials, enabling the release of novel therapeutics with more certainty and safety assurance than ever before. Oxford Nanopore Technologies plc (Oxford Nanopore) and PathoQuest today announce the agreement of a MOU for a collaboration to commercialise a transformational Integration Site […]
New product delivers up to 7kb of high-accuracy DNA in as fast as 7 days, providing an unparalleled combination of speed, length, and quality to the synthetic biology market San Carlos, Calif. — Elegen, a leader in DNA innovation, today announced that it has successfully concluded its early access program and is now offering global […]
NEW YORK — Dante Genomics, a global leader in genomics and precision medicine, launched today the beta version of Avanti, the Company’s proprietary B2B software for variant interpretation and report writing at scale. Avanti provides clinicians, geneticists and researchers with a plug-and-play web-based software UI that generates reports in less than five minutes, in parallel, for whole […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
